36 articles tagged
New federal legislation requiring work verification for Medicaid recipients is creating a major business opportunity for credit agency Equifax, which holds vast employment data.
Vertex Pharmaceuticals, known for its cystic fibrosis monopoly, is expanding into new markets like diabetes and pain management with a pipeline targeting millions of new patients.
Two major South Florida hospital systems are launching their own health insurance company, 22 Health, to compete in the state's bustling ACA marketplace.
Contract negotiations between Anthem and Northern Light Health have collapsed, forcing patients to pay higher out-of-network costs for medical care.
Cigna's stock fell over 17% despite reporting a 10% rise in Q3 revenue. Investor concern is focused on future profit pressure from new contracts and a shift to a rebate-free drug model.
UnitedHealth Group reported a 12% revenue increase to $113 billion in Q3, driven largely by federal Medicare payments despite a drop in commercial plan members.
Oregon health insurer PacificSource is laying off 381 employees, about 20% of its workforce, and exiting major Medicaid markets, impacting over 100,000 members.
Millions of Americans face sharp increases in health insurance premiums for 2026 as enhanced federal subsidies are set to expire amid a congressional stalemate.
Lehigh Valley Health Network has announced it will end its contracts with insurer UnitedHealthcare in 2026, a move that could affect thousands of patients.
Insurance giant Cigna Group has announced it will eliminate prescription drug rebates in many commercial health plans starting in 2027, a move that could reshape U.S. drug pricing.
Healthcare providers across the U.S. are set to receive payments from a $2.8 billion Blue Cross Blue Shield settlement. The claim deadline is July 29, 2025.
Starting in 2026, Mayo Clinic will no longer be an in-network provider for certain Medicare Advantage plans from UnitedHealthCare and Humana, affecting patients.
